维普中文期刊产品整合服务
48篇 您的检索式:作者名="Porter AC"
    题名 作者 年代 出处 被引量
1A p34(cdc2)survival checkpoint in cancer显示文摘O'Connor DS Wall NR Porter AC 2002Cancer Cell2002,2,1:1
2Prolidase deficiency and the biochemical assays used in its diagnosis显示文摘Kurien BT Patel NC Porter AC 2006Anal Biochem2006,349,2:1
3Construction, characterization, and complementation of a conditional-lethal DNA topoisomeraseⅡ alpha mutant human cell line 显示文摘Carpenter AJ Porter AC 2004Mol Biol Cell2004,15,12:1
4Ap34(cdc2) survival checkpoint in cancer显示文摘O'Connor DS Wall NR Porter AC 2002Cancer Cell2002,2,1:1
514-3-3 proteins interact with specific MEK kinases显示文摘Fanger GR Widmann C Porter AC 1998J Biol Chem1998,273,6:1
6A p34(cdc2) survival checkpoint in cancer显示文摘O'Connor DS Wall NR Porter AC 2002Cancer Cell2002,2,1:1
7Health-related quality of life in hyper- tension, chronic kidney disease, and coexistent chronic health conditions 显示文摘Soni RK Porter AC Lash JP 2010Adv Chronic Kidney Dis2010,17,4:1
8A p34 (cdc2) survival check point in cancer显示文摘O' Connor DS Wall NR Porter AC 2002Cancer Cell2002,2,1:1
9A p34(cdc2) survival checkpoint in cancer显示文摘O'Connor DS Wall NR Porter AC 2002Cancer Cell2002,2,1:1
10A p34(cdc2) survival checkpoint in cancer显示文摘O'Connor DS Wall NR Porter AC 2002Cancer Cell2002,2,1:1
11Ap34 (cdc2)survival checkpoint in cancer显示文摘O'CONNOR DS WALL NR PORTER AC 2002Cancer Cell2002,2,:1
12Critical roles for IFN- beta in lymphoid development, myelopoiesis, and tumor development: links to tumor necrosis faetor alpha显示文摘Deonarain R Verma A Porter AC 2003Proc Natl Acad Sci U S A2003,100,13:1
13A p34(cdc2) survival checkpoint in cancer显示文摘O'Connor DS Wall NR Porter AC 2002Cancer Cell2002,2,1:1
14Characterization ofa novel endocannabinoid,virodhamine,with antagonist activi- ty at the CB1 receptor 显示文摘Porter AC Saner JM Knierman MD 2002J Pharmacol Exp Ther2002,301,3:1
15Health - related quali- ty of life in Hispanics with chronic kidney disease 显示文摘PORTER AC VLJIL JC JR UNRUH M 2010Transl Res2010,155,4:1
16Sinal traduction pathways regulated by arsenate and a rsenite显示文摘 Fanger GR raillancount RR 1999On cogene1999,18,54:1
17Treatment with Gefitinib or Lapatinib Induces Drug Resistance through Downregulation of Topoisomerase Ⅱ αExpression显示文摘Bhosle J Kiakos K Porter AC 2013Mol cancer Ther2013,12,12:1
18Acetabular fracture pat- terns and their associated injuries显示文摘Porter SE Schroeder AC Dzugan SS 2008J Orthop Trauma2008,22,3:1
19Cellular and molecular mecha-nisms of endothelial dysfunction in diabetes 显示文摘Roberts AC Porter KE 2013Diab Vasc Dis Res2013,10,6:1
2014-3-3 Proteins interact with specific MEK kinases显示文摘Fanger GR Widmann C Porter AC 1998J Biol Chem1998,273,:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费